J Appl Biomed 14:187-197, 2016 | DOI: 10.1016/j.jab.2015.11.003

Biotherapies of rabbit serum modulate the immune response and decrease parasite load in mice infected with Trypanosoma cruzi

Fabiana Nabarro Ferraza,*, Franciele Karina da Veigaa, Denise Lessa Aleixoa, Larissa Ciupaa, Benício Alves de Abreu Filhob, Suelen Santos da Silvac, Ivete Conchon-Costac, Wander Rogério Pavanellic, Silvana Marques de Araújoa
a Department of Basic Health Science, Laboratory of Parasitology, Universidade Estadual de Maringá (UEM), Maringá, PR, Brazil
b Department of Basic Health Science, Laboratory of Microbiology, Universidade Estadual de Maringá (UEM), Maringá, PR, Brazil
c Department of Pathological Sciences, Laboratory of Experimental Immunoparasitology, Universidade Estadual de Londrina (UEL), Londrina, PR, Brazil

The use of biotherapies as intervention in murine infection with Trypanosoma cruzi is a possible means to understand the effects of these highly diluted medications. This study evaluated the effects of biotherapies that were prepared from rabbit serum uninfected (BSNI13c group) and chronically infected with Y strain of T. cruzi (BSI13c group), dynamization 13c, in mice experimentally infected. Parasitological, histopathological, and immunological parameters were evaluated. BSNI13c group exhibited the best outcome, including decreases in parasitemia and parasite load/inflammation in the heart, with pronounced Th1 response on days 8 and 12 after infection (a.i.) that was attributable to decrease in IL-4 concentrations, with no increases in TNF-α and IFN-γ, associated to decrease in IL-17A compared to control. In contrast, BSI13c group did not exhibit alterations in parasitemia but a significant decrease in parasite load/inflammation in the heart, with pronounced Th2 response on day 12 a.i. that was attributable to increase in IL-4 concentrations, with no changes in TNF-α and IFN-γ, associated to decrease in IL-17A compared to control. This study suggest that biotherapies that were prepared from rabbit serum uninfected and chronically infected with T. cruzi differentially modulate the immune system in mice infected with this protozoan, providing evidence of the actions of these medications.

Keywords: Trypanosoma cruzi; Animal model; Homeopathy; Biotherapy; Parasitemia; Tissue parasitism; Cytokines

Received: June 11, 2015; Revised: November 18, 2015; Accepted: November 19, 2015; Published: August 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nabarro Ferraz F, da Veiga FK, Lessa Aleixo D, Ciupa L, de Abreu Filho BA, da Silva SS, et al.. Biotherapies of rabbit serum modulate the immune response and decrease parasite load in mice infected with Trypanosoma cruzi. J Appl Biomed. 2016;14(3):187-197. doi: 10.1016/j.jab.2015.11.003.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Aleixo, D.L., Ferraz, F.N., Ferreira, E.C., de Lana, M., Gomes, M.L., de Abreu Filho, B.A., de Araújo, S.M., 2012. Highly diluted medication reduces parasitemia and improves experimental infection evolution by Trypanosoma cruzi. BMC Res. Notes 5, 352. Go to original source... Go to PubMed...
    2. Almeida, R.L., Campos, M.C.O., Herrera, L.V.B., Bonamin, L.V., Fonseca, A.H., 2008. Effects of homeopathy in mice experimentally infected with Trypanosoma cruzi. Homeopathy 97, 65-69. Go to original source... Go to PubMed...
    3. Araújo Jorge, T.C., Castro, S.L., 2000. Doença de Chagas: Manual para experimentação animal. FioCruz, Rio de Janeiro. Go to original source...
    4. Bell, I.R., Koithan, M., 2012. A model for homeopathic remedy effects: low dose nanoparticles, allostatic cross-adaptation, and time-dependent sensitization in a complex adaptive system. BMC Complement. Altern. Med. 12, 191. Go to original source... Go to PubMed...
    5. Bellavite, P., Conforti, A., Ortolani, R., 2006a. Immunology and homeopathy. 3. Experimental studies on animal models. Evid. Based Complement. Alternat. Med. 3, 171-186. Go to original source... Go to PubMed...
    6. Bellavite, P., Conforti, A., Piasere, V., Ortolani, R., 2005. Immunology and homeopathy. 1. Historical background. Evid. Based Complement. Alternat. Med. 2, 441-452. Go to original source... Go to PubMed...
    7. Bellavite, P., Conforti, A., Pontarollo, F., Ortolani, R., 2006b. Immunology and homeopathy. 2. Cells of the immune system and inflammation. Evid. Based Complement. Alternat. Med. 3, 13-24. Go to original source... Go to PubMed...
    8. Bonamin, L.V., Endler, P.C., 2010. Animal models for studying homeopathy and high dilutions: conceptual critical review. Homeopathy 99, 37-50. Go to original source... Go to PubMed...
    9. Bonamin, L.V., Sato, C., Zalla Neto, R., Morante, G., Cardoso, T.N., de Santana, F.R., Coelho, C.P., Osugui, L., Popi, A.F., Hurtado, E.C., Mariano, M., 2013. Immunomodulation of homeopathic thymulin 5CH in a BCG-induced granuloma model. Evid. Based Complement. Alternat. Med. 2013 15. Go to original source... Go to PubMed...
    10. Brasil, 2011. Farmacopeia Homeopática Brasileira, 3a edição. ANVISA, Brasília.
    11. Brasil, 2015a. Presidência da República. Lei N∘ 11.794, de 8 de outubro de 2008. Estabelece procedimento para o uso científico de animais. http://www.planalto.gov.br/ccivil_03/_ato2007-2010/2008/lei/l11794.htm (accessed: April 14).
    12. Brasil, 2015b. Ministério da Saúde. RDC N∘ 67, de 8 de outubro de 2007. Dispõe sobre boas práticas de manipulação de preparações magistrais e oficinais para uso humano em farmácias. http://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2007/res0067_08_10_2007.html (accessed: April 14).
    13. Brener, Z., 1965. Comparative studies of different strains of Trypanosoma cruzi. Ann. Trop. Med. Parasitol. 59, 19-26. Go to original source... Go to PubMed...
    14. Brener, Z., 1962. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev. Inst. Med. Trop. São Paulo 4, 389-396.
    15. Chikramane, P.S., Suresh, A.K., Bellare, J.R., Kane, S.G., 2010. Extreme homeopathic dilutions retain starting materials: a nanoparticulate perspective. Homeopathy 99, 231-242. Go to original source... Go to PubMed...
    16. Clausen, J., Van, W.R., Albrecht, H., 2011. Review of the use of high potencies in basic research on homeopathy. Homeopathy 100, 288-292. Go to original source... Go to PubMed...
    17. Coura, J.R., Dias, J.C., 2009. Epidemiology, control and surveillance of Chagas disease - 100 years after its discovery. Mem. Inst. Oswaldo Cruz 104, 31-40. Go to original source... Go to PubMed...
    18. da Matta Guedes, P.M., Gutierrez, F.R., Maia, F.L., Milanezi, C.M., Silva, G.K., Pavanelli, W.R., Silva, J.S., 2010. IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis. PLoS Negl. Trop. Dis. 4, e604. Go to original source...
    19. Erdmann, H., Roßnagela, C., Böhmea, J., Iwakurac, Y., Jacobsd, T., Schaiblee, U.E., Hölscher, C., 2013. IL-17A promotes macrophage effector mechanisms against Trypanosoma cruzi by trapping parasites in the endolysosomal compartment. Immunobiology 218, 910-923. Go to original source... Go to PubMed...
    20. Faria Neto, H.C.C., dos Santos, B.F., 2008. Fármacos usados em animais de laboratório anestésicos e analgésicos. In: Manual de utilização de animais. FioCruz, Rio de Janeiro20-27.
    21. Ferraz, F.N., Bilotti, C.C., Aleixo, D.L., Martinichen-Herrero, J.C., Nascimento Junior, A.D., de Araújo, S.M., 2014. Hematological and parasitological changes in mice experimentally infected by Trypanosoma cruzi and treated with biotherapy 7dH. Eur. J. Integr. Med. 6, 664-671. Go to original source...
    22. Ferraz, F.N., da Veiga, F.K., Aleixo, D.L., da Silva, S.S., Conchon- Costa, I., Pavanelli, W.R., de Araújo, S.M., 2015. Modulation of IFN-g, IL-4, and IL-17 cytokines is related to parasitemia control in mice infected by Trypanosoma cruzi and treated with biotherapy. Online J. Biol. Sci. (in press). Go to original source...
    23. Q9
    24. Ferraz, F.N., da Veiga, F.K., Moreira, N.M., Brustolin, C.F., Lopes, C.R., Falkowski, G.J.S., Aleixo, D.L., Holandino, C., de Araújo, S.M., 2013. Evaluation of effect of succussed and unsucussed homeopathic vehicle on murine infection by Trypanosoma cruzi. Proceedings of the XXVII GIRI Symposium 2013, Sep. 03-04, Bern, Switzerland. Int. J. High Dilution Res. 12, 91-92.
    25. Ferraz, F.N., Simoni, G.K., do Nascimento, A., de Melo, C.S., Aleixo, D.L., Gomes, M.L., Spack, M., de Araújo, S.M., 2011. Different forms of administration of biotherapy 7dH in mice experimentally infected by Trypanosoma cruzi produce different effects. Homeopathy 100, 237-243. Go to original source... Go to PubMed...
    26. Fontes, O.L., Cesar, A.T., Chaud, M.V., Teixeira, M.Z., Kishi, M.A., Amorim, V.O., 2009. Farmácia homeopática: teoria e prática, 3 edição. Editora Manole, São Paulo.
    27. Galesanu, M., 2014. Tratamento homeopático na tiroidite autoimune: relato de caso. Revista de Homeopatia 74, 25-27.
    28. Gazzinelli, R.T., Oswald, I.P., Hieny, S., James, S.L., Sher, A., 1992. The microbicidal activity of interferon-g treated macrophages against Trypanosoma cruzi involves an L- arginine-dependent, nitrogen oxide-mediated mechanism inhabitable by interleukin-10 and transforming growth factor-b. Eur. J. Immunol. 22, 2501-2506. Go to original source... Go to PubMed...
    29. Gholamnezhad, Z., Boskabady, M.H., Hosseini, M., 2014. Effect of Nigella sativa on immune response in treadmill exercised rat. BMC Complement. Altern. Med. 14, 437. Go to original source... Go to PubMed...
    30. Guedes, P.M., Silva, G.K., Gutierrez, F.R., Silva, J.S., 2011. Current status of Chagas disease chemotherapy. Expert. Rev. Anti Infect. Ther. 9, 609-620. Go to original source... Go to PubMed...
    31. Hölscher, C., Mohrs, M., Dai, W.J., Köhler, G., Ryffel, B., Schaub, G. A., Mossmann, H., Brombacher, F., 2000. Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi- infected interleukin 10-deficient mice. Infect. Immun. 68, 4075-4083. Go to original source... Go to PubMed...
    32. Horta, I., 2012. Estudo prospectivo observacional de uma série de casos de dor osteomusculoarticular crônica com organoterápicos associados ao tratamento homeopático convencional. Revista de Homeopatia 75, 1-13.
    33. Hunter, C.A., Ellis-Neyes, L.A., Slifer, T., Kanaly, S., Grünig, G., Fort, M., Rennick, D., Araujo, F.G., 1997. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158, 3311-3316. Go to original source... Go to PubMed...
    34. Lorenzi, T.F., 2006. Manual de hematologia: Propedêutica e clínica, 4 edição. Guanabara Koogan, Rio de Janeiro.
    35. Magalhães, J.B., Pontes, A.L., Andrade, S.G., 1985. Comportamento das cepas Y e Peruana do Trypanosoma cruzi no camundongo, após passagem em diferentes meios. Mem. Inst. Oswaldo Cruz 80, 41-50. Go to original source... Go to PubMed...
    36. Melo, R.C., Brener, Z., 1978. Tissue tropism of different Trypanosoma cruzi strains. J. Parasitol. 64, 475-482. Go to original source... Go to PubMed...
    37. Michailowsky, V., Silva, N.M., Rocha, C.D., Vieira, L.Q., Vieria, J.L., Gazzinelli, R.T., 2001. Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection. Am. J. Pathol. 159, 1723-1733. Go to original source... Go to PubMed...
    38. Miyazaki, Y., Hamano, S., Wang, S., Shimanoe, Y., Iwakura, Y., Yoshida, H., 2010. IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection. J. Immunol. 185, 1150-1157. Go to original source... Go to PubMed...
    39. Monteiro, A.C., Schmitz, V., Morrot, A., de Arruda, L.B., Nagajyothi, F., Granato, A., Pesquero, J.B., Müller-Esterl, W., Tanowitz, H.B., Scharfstein, J., 2007. Bradykinin B2 Receptors of dendritic cells, acting as sensors of kinins proteolytically released by Trypanosoma cruzi, are critical for the development of protective type-1 responses. PLoS Pathog. 3, e185. Go to original source... Go to PubMed...
    40. Munoz-Fernandez, M.A., Fernandez, M.A., Fresno, M., 1992. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and IFN- gamma through a nitric oxide-dependent mechanism. Immunol. Lett. 33, 35-40. Go to original source... Go to PubMed...
    41. Pedalino, C.M., Perazzo, F.F., Carvalho, J.C., Martinho, K.S., Massoco, C.O., Bonamin, L.V., 2004. Effect of Atropa belladonna and Echinacea angustifolia in homeopathic dilution on experimental peritonitis. Homeopathy 93, 193-198. Go to original source... Go to PubMed...
    42. Queiroz, A.O., Xavier, S.C.C., Faria, K.G., Bernardo, R.R., Leitão, T. C.A., 2006. Avaliação do bioterápico Trypanosoma cruzi 30 DH: Um estudo in vivo. Cultura Homeopática 17, 9-13.
    43. Rocha, M.O., Teixeira, M.M., Ribeiro, A.L., 2007. An update on the management of Chagas cardiomyopathy. Expert. Rev. Anti Infect. Ther. 5, 727-743. Go to original source... Go to PubMed...
    44. Rodrigues de Santana, F., Coelho, C.P., Cardoso, T.N., Laurenti, M.D., Perez Hurtado, E.C., Bonamin, L.V., 2014a. Modulation of inflammation response to murine cutaneous Leishmaniosis by homeopathic medicines: Thymulin 5Ch. Homeopathy 103, 275-284. Go to original source... Go to PubMed...
    45. Rodrigues de Santana, F., Coelho, C.P., Cardoso, T.N., Perez Hurtado, E.C., Roberti Benites, N., Laurenti, M.D., Bonamin, L. V., 2014b. Modulation of inflammation response to murine cutaneous Leishmaniasis by homeopathic medicines: Antimonium crudum 30Ch. Homeopathy 103, 264-274. Go to original source... Go to PubMed...
    46. Sandri, P., Aleixo, D.L., Sanchez Falkowski, G.J., Nascimento Júnior, A.D., Gomes, M.L., Hernandes, L., Dalalio, M.M.O., Moreira, N.M., Toledo, M.J., Gabriel, M., de Araújo, S.M., 2015. Trypanosoma cruzi: biotherapy made from trypomastigote modulates the inflammatory response. Homeopathy 104, 48-56. Go to original source... Go to PubMed...
    47. Santos-Lima, E.C., Garcia, V., Vicentelli, M.H., Vassalli, P., Minoprio, P., 1997. Evidence for a protective role of tumor necrosis factor in the acute phase of Trypanosoma cruzi infection in mice. Infect. Immun. 65, 457-465. Go to original source... Go to PubMed...
    48. Seder, R.A., Paul, W.E., 1994. Acquisition of lymphokine- producing phenotype by CD4+ T cells. Annu. Ver. Immunol. 12, 635-673. Go to original source... Go to PubMed...
    49. Silva, L.H.P., Nussenzweig, V., 1953. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para camundongo branco. Folia Clin. Biol. 20, 191-208.
    50. Stumhofer, J.S., Laurence, A., Wilson, E.H., Huang, E., Tato, C.M., Johnson, L.M., Villarino, A.V., Huang, Q., Yoshimura, A., Sehy, D., Saris, C.J., O'Shea, J.J., Hennighausen, L., Ernst, M., Hunter, C.A., 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7, 937-945. Go to original source... Go to PubMed...
    51. Temporini, G.J.S.F., Lopes, C.R., Brustolin, C.F., Massini, P.F., Ferreira, E.C., Veiga, F.K., Aleixo, D.L., Pala, N.R., Barion, T., Esper, L.G., de Araújo, S.M., 2012. Causticum hahnemanni, Conium maculatum and Lycopodium clavatum highly diluted medications decreases parasitemia in mice infected by Trypanosoma cruzi. Proceedings of the XXVI GIRI Symposium 2012, Sep. 20-22, Florence, Italy. Int. J. High Dilution Res. 11, 198-199. Go to original source...
    52. Tesmer, L.A., Lundy, S.K., Sarkar, S., Fox, D.A., 2008. Th17 cells in human disease. Immunol. Rev. 223, 87-113. Go to original source... Go to PubMed...
    53. Witt, C.M., Bluth, M., Albrecht, H., Weisshuhn, T.E., Baumgartner, S., Willich, S.N., 2007. The in vitro evidence for an effect of high homeopathic potencies - a systematic review of the literature. Complement. Ther. Med. 15, 128-138. Go to original source... Go to PubMed...
    54. World Health Organization (WHO), 2015. Chagas disease (American trypanosomiasis). Fact sheet No. 340. http://www.who.int/mediacentre/factsheets/fs340/en/ (accessed: April 14).
    55. Zelante, T., De Luca, A., Bonifazi, P., Montagnoli, C., Bozza, S., Moretti, S., Belladonna, M.L., Vacca, C., Conte, C., Mosci, P., Bistoni, F., Puccetti, P., Kastelein, R.A., Kopf, M., Romani, L., 2007. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 37, 2695-2706. Go to original source... Go to PubMed...
    56. Zingales, B., Andrade, S.G., Briones, M.R., Campbell, D.A., Chiari, E., Fernandes, O., Guhl, F., Lages-Silva, E., Macedo, A.M., Machado, C.R., Miles, M.A., Romanha, A.J., Sturm, N.R., Tibayrenc, M., Schijman, A.G., 2009. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem. Inst. Oswaldo Cruz 104, 1051-1054. Go to original source... Go to PubMed...

    Return to the content